Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

Real progress in health inequities requires meeting communities where they are and addressing the root causes of medical ...

The bidirectional research examines both laboratory findings and human clinical trial data, revealing that the medicinal use ...

In a discussion with the Cobb Institute, Dr. Priscilla Pemu and Tesheia Harris shared insights on how to make clinical trials more inclusive.

At the OCT DACH conference, experts shared how EU laws, digitalisation, and more, are impacting trials in the DACH region and ...

An AI tool called Muse aims to optimize clinical trial patient recruitment and accelerate the development of new therapies.

Clinical trials are a significant part of the drug development cycle. However, the process has remained unchanged in recent ...

Nothing about pregnancy diminishes an individual’s decision-making capacity or obviates their right to make decisions related ...

Incorporating Africa into the clinical trial landscape will attract significant investment, create jobs, and boost the local ...

THEO-260 is a mechanistically novel oncolytic immunotherapy developed to tackle the stromal rich tumour microenvironment (TME) evident in ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...